LORA REYNOLDS: Open Payments
NPI 1063838654 · ABINGDON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,727 in 86 payments from 21 companies in 2025. Trend: 2023 $8,439 · 2024 $2,805 · 2025 $1,727
Food & beverage: $1,727
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 27 | $557 |
| Amgen Inc. | 13 | $160 |
| Medtronic, Inc. | 3 | $132 |
| Abbott Laboratories | 7 | $119 |
| Dexcom, Inc. | 6 | $118 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $69 |
| Sequel Med Tech, LLC | 2 | $60 |
| Novartis Pharmaceuticals Corporation | 3 | $59 |
| Corcept Therapeutics | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
Products named: Wegovy, Ozempic, MINIMED 780G, Rybelsus, FREESTYLE LIBRE 3, Dexcom G6 Transmitter, REPATHA, JARDIANCE.
Industry payments across VA — which companies pay providers there.
